Moreover, despite the influence of tumor stroma and leucocyte infiltration in CRC progression [12,13,14], previous studies did not evaluate the influence of PTGS2 expressed by non-tumor cells on patient prognosis. This evidence concerns the gene PTGS2 and colorectal carcinoma.